READ MORE avandia LEGAL NEWS
In 2007, Dr. Steven Nissen published a study linking the drug with a 43 percent increased risk of heart attacks. In September 2010, the Food and Drug Administration severely restricted the use of Avandia, while the European Medicines Agency banned it all together.
According to a report in the New York Times, GSK settled some 10,000 of 13,000 Avandia product liability suits in the US in 2010 at a cost of $2.36 billion. However, since then, GSK has received substantial new claims the company said in a statement to the London Stock Exchange.
In 2010, GSK also faced investigations into its antidepressant Paxil.